Gene · 8658
Papers2,155
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,155
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Uncovering Phenotypic Expansion in AXIN2-Related Disorders through Precision Animal Modeling. | medRxiv | 2025 | 39677486 | PubTator, text mining | PubMed |
| AXIN2 is a non-redundant regulator of AXIN1 stability and β-catenin in colorectal cancer cells. | FEBS J | 2025 | 39587396 | PubTator, text mining | PubMed |
| Blastocoel expansion and AMOT degradation cooperatively promote YAP nuclear localization during epiblast formation. | Dev Biol | 2025 | 39486633 | PubTator, text mining | PubMed |
| Targeting Wnt Pathways with Small Molecules as New Approach in Cardiovascular Disease. | Curr Cardiol Rev | 2025 | 39482911 | PubTator, text mining | PubMed |
| A functional genomic framework to elucidate novel causal metabolic dysfunction-associated fatty liver disease genes. | Hepatology | 2025 | 39190705 | PubTator, text mining | PubMed |
| AXIN2 promotes degradation of AXIN1 through tankyrase in colorectal cancer cells. | FEBS J | 2025 | 39022865 | PubTator, text mining | PubMed |
| SASH1 S519N Variant Links Skin Hyperpigmentation and Premature Hair Graying to Dysfunction of Melanocyte Lineage. | J Invest Dermatol | 2025 | 38848986 | PubTator, text mining | PubMed |
| Deciphering epistatic genetic regulation of cardiac hypertrophy. | medRxiv | 2025 | 37987017 | PubTator, text mining | PubMed |
| Exploring the Effects of Chirality of 5-methyl-5-[4-(4-oxo-3H-quinazolin-2- yl)phenyl]imidazolidine-2,4-dione and its Derivatives on the Oncological Target Tankyrase 2. Atomistic Insights. | Curr Pharm Biotechnol | 2025 | 37005548 | PubTator, text mining | PubMed |
| PARP enzyme de novo synthesis of protein-free poly(ADP-ribose). | Mol Cell | 2024 | 39536748 | PubTator, text mining | PubMed |
| Tankyrase inhibition promotes endocrine commitment of hPSC-derived pancreatic progenitors. | Nat Commun | 2024 | 39384787 | PubTator, text mining | PubMed |
| RETRACTION: Antisense inhibition of Bcr-Abl/c-Abl synthesis promotes telomerase activity and upregulates tankyrase in human leukemia cells. | FEBS Lett | 2024 | 39291729 | PubTator, text mining | PubMed |
| Regulation of PARP1/2 and the tankyrases: emerging parallels. | Biochem J | 2024 | 39178157 | PubTator, text mining | PubMed |
| A genome-wide screen links peroxisome regulation with Wnt signaling through RNF146 and TNKS/2. | J Cell Biol | 2024 | 38967608 | PubTator, text mining | PubMed |
| Study of the mechanism by which Xiaoyan decoction combined with E7449 regulates tumorigenesis in lung adenocarcinoma. | J Cell Mol Med | 2024 | 38898581 | PubTator, text mining | PubMed |
| 3D layered co-culture model enhances Trastuzumab Deruxtecan sensitivity and reveals the combined effect with G007-LK in HER2-positive non-small cell lung cancer. | Biochem Biophys Res Commun | 2024 | 38897043 | PubTator, text mining | PubMed |
| Hypoxia differently regulates the proportion of ALDHhi cells in lung squamous carcinoma H520 and adenocarcinoma A549 cells via the Wnt/β-catenin pathway. | Thorac Cancer | 2024 | 38736300 | PubTator, text mining | PubMed |
| A low-cost spectroscopic nutrient management system for Microscale Smart Hydroponic system. | PLoS One | 2024 | 38718016 | PubTator, text mining | PubMed |
| Design, Synthesis, and In Silico and In Vitro Cytotoxic Activities of Novel Isoniazid-Hydrazone Analogues Linked to Fluorinated Sulfonate Esters. | ACS Omega | 2024 | 38645328 | PubTator, text mining | PubMed |
| PI3K and tankyrase inhibitors as therapeutic targets in colorectal cancer. | Expert Opin Ther Targets | 2024 | 38497299 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8658/papers?page=5